Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants
PHASE3CompletedINTERVENTIONAL
Enrollment
254
Participants
Timeline
Start Date
December 31, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
Conditions
DiphtheriaPolioPertussisHepatitis B
Interventions
BIOLOGICAL
DTaP-IPV-HB-PRP~T vaccine
0.5 mL, intramuscular (IM)
Trial Locations (1)
Unknown
Ankara
All Listed Sponsors
lead
Sanofi Pasteur, a Sanofi Company
INDUSTRY
NCT00619502 - Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants | Biotech Hunter | Biotech Hunter